Who makes aspirin and ketamine?

aspirin and ketamine is developed by Antonios Likourezos.

What development phase is aspirin and ketamine in?

aspirin and ketamine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

aspirin and ketamine

Antonios Likourezos · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	aspirin and ketamine
Sponsor	Antonios Likourezos
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain (PHASE4)
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression (PHASE4)
An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache (PHASE4)
Analgesic Efficacy of Orally Administered VTS-K for Pain Management
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

aspirin and ketamine CI brief — competitive landscape report
aspirin and ketamine updates RSS · CI watch RSS
Antonios Likourezos portfolio CI